During the past decade, Clinical Research Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute" #1 sponsor was "National Institute of Mental Health (NIMH)" with 4 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored, "Cyberonics, Inc." with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored and "FORUM Pharmaceuticals Inc" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute" #1 collaborator was "Duke University" with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator, "Otsuka America Pharmaceutical" with 1 trials as a collaborator and "University of North Carolina, Chapel Hill" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute" are "Schizophrenia" (5 trials), "Major Depressive Disorder" (4 trials), "Schizoaffective Disorder" (3 trials), "Depression" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute" are "Drug" (15 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Androderm® (Positive Control)" (1 trials), "Antipsychotic therapy" (1 trials), "Aripiprazole" (1 trials) and "Desvenlafaxine Succinate Sustained-Release (DVS SR)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinical Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".